Practice Areas
Claudia Götz Staehelin specialises in dispute resolution and investigations, representing and advising clients in complex domestic and cross-border court and arbitration proceedings. She is a trusted expert in internal and government-led investigations, with particular experience in white-collar crime, bribery, fraud, sanctions, ESG, and workplace incidents. She also has extensive expertise in international legal assistance, asset tracing, and compliance.
Claudia regularly advises clients across a range of industries, including technology, industrial, chemical and raw materials, and financial services, with a notable focus on highly regulated industries such as pharmaceuticals, life sciences, and healthcare. Her deep understanding of pharmaceutical regulatory matters, compliance risks, and industry-specific disputes makes her a sought-after advisor in these sectors.
With over 20 years of experience, including as Head of Litigation at Novartis, Claudia is well-versed in navigating high-stakes disputes, sensitive regulatory proceedings, and crisis management. She is also active as an arbitrator, particularly in ICC and Swiss Rules arbitrations.
Publications
The New In-House Privilege (Legal Insight Series on the Revision of the Swiss Civil Procedural Code), 6 December 2024 (together with Pascal Hachem)
Cross-border Investigations in the Pharma Industry, in: Macaluso/Moreillon/Lombardini/Garbarski (eds.), Développements récents en droit pénal de l'entreprise V, 63 et seq., Berne 2024 (together with Djamila Batache and Daniel Senn)
Legal Privilege in Internal Investigations – Recent Swiss Federal Supreme Court Rulings, Briefing, 5 September 2024 (together with Eric Stupp, Joel Fischer, Massimo Chiasera, Oliver M. Brupbacher, and Caroline Hochstrasser)
Höchstrichterliche Vereinfachung und Klärung zum Arrest in komplexen nationalen und internationalen Verhältnissen, in: Catelli/Sunaric (eds.), Zuständigkeit – Erkenntnisse aus der Praxis, page 57 et seq., Zurich 2024 (together with Oliver M. Brupbacher and Daniel Senn)
Trade Secrets 2024 – Trends & Developments, Chambers Global Practice Guide, 23 May 2024 (together with Oliver M. Brupbacher)
Pharmaceutical Advertising 2024, Chambers Global Practice Guide, 7 April 2024 (together with Oliver M. Brupbacher, Djamila Batache, and Christine Schweikard)
Product Liability 2024, Chambers Global Practice Guide, 5 April 2024 (together with Oliver M. Brupbacher, Daniel Senn)
Life Sciences 2024, Chambers Global Practice Guide, 4 April 2024 (together with Oliver M. Brupbacher, Djamila Batache, and Christine Schweikard)
Federal Supreme Court: No Criminal Due Process Guarantees in Corporate Internal Investigations, Briefing, 20 February 2024 (together with Eric Stupp, Joel Fischer, Laura Widmer, Oliver M. Brupbacher, Andrew M. Garbarski, Massimo Chiasera, Gadi Winter)
Revision of the Swiss Criminal Procedural Law on the Sealing of Evidence, Briefing, 16 January 2024 (together with Oliver M. Brupbacher and Andrew M. Garbarski)
Company Convicted for Insufficient Compliance Measures Against Bribery, Briefing, 2 May 2023 (together with Massimo Chiasera, Joel Fischer, Marlen Schultze)
Anti-Corruption 2023, Chambers Global Practice Guide, 22 March 2023 (together with Florian Baumann, Roman Huber, Lea Ruckstuhl)
Product Liability 2021, Legal 500 Country Comparative Guide, 23 June 2022 (together with Laura Manz)
Herausforderungen durch Cybersecurity in der modernen Unternehmensrealität, SJZ 2022, 512 et seq. (together with Oliver M. Brupbacher)
Sie haben das Recht zu Schweigen – Oder doch nicht? Recht relevant,2/2022 (together with Marlen Schultze)
Fraud, Asset Tracing & Recovery in Switzerland, CDR 2021 (together with Florian Baumann)
Corona-Kredite für KMU, Art. 5-8 SBüG, in: Kellerhals/Carrard/Bürgschaftsgenossenschaft Schweiz (Hrsg.), Zürich/Basel/Genf 2021 (together with Daniel Lengauer)
Early and Managed Access to Medicine in Switzerland, Life Sciences Recht, 3/2021, 149 et seq. (together with Oliver M. Brupbacher)
Der indirekte Gegenvorschlag zu Konzernverantwortungsinitiative, Recht relevant für Verwaltungsräte, 4/2021 (together with Marlen Schultze)
Arbeitsplatzuntersuchungen in der #MeToo-Ära, Recht relevant, 1/2020 (together with Melanie Huber)
Unternehmensinterne Untersuchungen, Schulthess Manager Dossier
Commentary to Art. 2-4 und 59-62 LugÜ, in: C. Oetiker/T. Weibel (eds.), Kommentar zum Lugano-Übereinkommen, Basel 2011 (together with Roberto Dallafior)
Institutional Arbitration: Tasks and Powers of different Arbitration Institutions (eds., together with Karin Graf, Pascale Gola)
Prozessuale Hürden in Verantwortlichkeitsprozessen, GesKR 4/2009, 479 et seq. (together with Simone Stebler)
Überblick über die wichtigsten Änderungen des Lugano-Übereinkommens, SJZ 2008, 105 (together with Roberto Dallafior)
Die Ausgestaltung der Honorarvereinbarung – Das Problem des "Windfalls" und des Erfolgshonorars, SJZ 2007, 471 et seq. (together with Hans Nater)
Teamarbeit und geteilte Verantwortung in Spital, Arztpraxis und Belegarztverhältnis, HAVE 2007, 226 et seq.
Amerikanisches Discovery für Verfahren im Ausland, SJZ 2006, 269 et seq.
Der Gerichtsstand der rügelosen Einlassung im Zivilprozessrecht der Schweiz, Schriftenreihe für Internationales Recht der juristischen Fakultät der Universität Basel
